23711-41-3 Usage
General Description
The chemical compound "(4E)-4-{[(4-hydroxyphenyl)amino]methylidene}-5-methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one" is a complex organic molecule with an extended structure. It contains a pyrazolone ring with a methyl and phenyl substituent, as well as an amino group and a hydroxyphenyl group. The compound also features a methylene group connected to the amino and hydroxyphenyl substituents. Its chemical name indicates a potential biological activity, possibly as an inhibitor or modulator of enzymes or receptors, due to the presence of the phenyl and hydroxyphenyl groups that are known to interact with biomolecules. However, further research is needed to fully understand the potential uses and effects of this compound.
Check Digit Verification of cas no
The CAS Registry Mumber 23711-41-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,7,1 and 1 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 23711-41:
(7*2)+(6*3)+(5*7)+(4*1)+(3*1)+(2*4)+(1*1)=83
83 % 10 = 3
So 23711-41-3 is a valid CAS Registry Number.
23711-41-3Relevant articles and documents
Synthesis, antitumor activity and QSAR studies of some 4-aminomethylidene derivatives of edaravone
Markovic, Violeta,Eric, Slavica,Juranic, Zorica D.,Stanojkovic, Tatjana,Joksovic, Ljubinka,Rankovic, Branislav,Kosanic, Marijana,Joksovic, Milan D.
, p. 18 - 27 (2011/04/15)
A series of aminomethylidene derivatives obtained from 4-formyledaravone were synthesized and characterized by IR, NMR and elemental analysis. All the compounds were screened for their antitumor activity. The compound containing 5-phenylpyrazole moiety (3q) exhibited remarkable antitumor activity in in vitro assays, especially against human breast cancer MDA-MB-361 and MDA-MB-453 cell lines. The most important whole-molecule descriptors for antitumor activity on MDA-MB-453 cells belong to the group of quantum-chemical descriptors.